| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 42, 612-613, Copyright © 1995 by Canadian Anesthesiologists' Society
ARTICLES |
K Janis, J Hess, JA Fabian and M Gillis
Anesthesiology Service, Veterans Administration Medical Centre, Albuquerque, NM, USA.
Three cases are reported where pre-existing medical conditions (severe osteoporosis, amyotrophic lateral sclerosis, cardiac arrhythmias) made the administration of succinylcholine during ECT potentially dangerous. Therefore, mivacurium was substituted as the muscle relaxant necessary for safe therapy. Full reversal of the non-depolarizing muscle relaxant was assured by post-reversal use of the peripheral nerve stimulator with full recovery of train-of-four response.
This article has been cited by other articles:
![]() |
A. G. Kadar, B. A. Kramer, M. C. Barth, and P. F. White Rapacuronium: An Alternative To Succinylcholine For Electroconvulsive Therapy Anesth. Analg., May 1, 2001; 92(5): 1171 - 1172. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |